NovoCure Target Price

Analysts' average 12-month price target for NovoCure is $38.

Get informed when a big investor buys or sells

+ Follow

Share Price

$15.51

Average Target Price

$37.50

141.8% upside

4 analysts in the last 4 months

High: $52 | Low: $20

Analyst Recommendations

No recommendations in the last 4 months.

Revenue & Income Forecast

Analysts' Target Prices

Date	Analyst	Price Target	Current Upside/Downside
2026-07-24	Wedbush	$20	28.9% upside
2026-07-24	H.C. WainwrightEmily Bodnar	$32	106.3% upside
2026-07-23	H.C. Wainwright	$52	235.3% upside
2026-06-18	H.C. WainwrightEmily Bodnar	$46	196.6% upside
2026-02-12	H.C. Wainwright	$47	203% upside
2026-01-13	H.C. Wainwright	$39	151.5% upside
2026-01-05	Evercore ISI	$20	28.9% upside
2025-10-30	H.C. Wainwright	$42	170.8% upside
2025-07-24	Wells FargoLarry Biegelsen	$14.5	6.5% downside
2024-12-02	Evercore ISIVijay Kumar	$30	93.4% upside
2024-10-16	H.C. WainwrightEmily Bodnar	$30	93.4% upside
2024-07-26	H.C. WainwrightEmily Bodnar	$24	54.7% upside
2024-05-03	H.C. WainwrightEmily Bodnar	$22	41.8% upside
2024-05-02	Evercore ISIVijay Kumar	$14.5	6.5% downside
2024-04-10	Piper SandlerJason Bednar	$28	80.5% upside
2024-04-03	Wells FargoLarry Biegelsen	$42	170.8% upside
2024-03-27	H.C. Wainwright	$24	54.7% upside
2023-01-06	J.P. Morgan	$99	538.3% upside
2023-01-06	Wells Fargo	$107	589.9% upside
2023-01-05	H.C. WainwrightEmily Bodnar	$140	802.6% upside
2022-11-29	Wells Fargo	$89	473.8% upside
2022-05-16	H.C. WainwrightEmily Bodnar	$115	641.5% upside
2022-02-08	Loop Capital MarketsJason Wittes	$200	1189.5% upside

NovoCure (NVCR) FAQ

NovoCure posts a target price of $38. Comparing that reading with peers and prior periods is usually more useful than looking at the number in isolation.

A target price of $38 for NVCR means covering analysts, on average, see the stock 141.8% upside of $15.51 over about 12 months. Dig into who set the high and low targets and how recently they updated — freshness matters as much as the average itself.

Context for NVCR's target price usually means three checks: (1) trend versus prior periods, (2) level versus peers, and (3) consistency with growth and profitability. This page covers the first two; NovoCure's other metric pages and overview cover the third.

Judging NovoCure against Healthcare peers is usually better than using a market-wide rule of thumb. Business models inside Healthcare are more comparable, which makes gaps in target price easier to interpret. Start with $38 here, then scan peer and history charts to see if the gap is persistent.